Umiflo Plus 100 Respicap 1s

AboutUmiflo Plus 100 Respicap is a combination inhalation medication containing fluticasone furoate, umeclidinium, and vilanterol, used for long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. It helps open airways, reduce inflammation, and improve breathing.Usage InstructionsUse one respicap once daily via inhaler device at the same time each day. Do not swallow the capsule. Insert capsule into inhaler device and inhale deeply. Rinse mouth after use. Not for acute symptom relief.Benefits- Long-lasting bronchodilation (24 hours)- Reduces airway inflammation- Improves lung function- Once-daily convenient dosingHow it WorksFluticasone (corticosteroid) reduces airway inflammation. Umeclidinium (LAMA) and vilanterol (LABA) relax airway smooth muscles through different mechanisms, providing synergistic bronchodilation and improved airflow.Side EffectsMay cause headache, throat irritation, cough, dry mouth, or hoarseness. Rare reports of paradoxical bronchospasm, urinary retention, or increased eye pressure.Safety AdviceNot for acute bronchospasm; keep rescue inhaler available. Inform doctor of glaucoma, prostate enlargement, heart disease, or thyroid problems. Rinse mouth after use to prevent oral thrush. Avoid contact with eyes. Use only with prescribed inhaler device. Not recommended during pregnancy or breastfeeding.StorageStore respicaps below 25°C in original blister pack. Protect from moisture and light. Do not remove from blister until ready to use. Keep out of reach of children.